Homology Medicines Inc
SWB:35H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Homology Medicines Inc
SWB:35H
|
US |
|
T
|
Takkt AG
F:TTK
|
DE |
|
Orthex Oyj
F:4QU
|
FI |
Shareholder Yield
Current shareholder yield for 
35H is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
35H Price
Homology Medicines Inc
| Average Annual Return | -49.71% |
| Standard Deviation of Annual Returns | 25.47% |
| Max Drawdown | -94% |
| Market Capitalization | 237.4m EUR |
| Shares Outstanding | 273 388 087 |
| Percentage of Shares Shorted |
N/A
|
35H Return Decomposition
Main factors of price return
Stock Splits
35H's latest stock split occurred on Mar 25, 2024
The company executed a 1-for-18 stock split, meaning that for every 18 shares held, investors received 1 new share.
Before the split, 35H traded at 14.85 per share. Afterward, the share price was about 14.85.
The adjusted shares began trading on Mar 25, 2024. This was the only stock split in 35H's history.
